AGEN Agenus Inc: Multiplikator Forward P/S
Competition in immuno-oncology and a shortage of funds are weakening the defensive barriers of Agenus (AGEN). However, the automation of bioreactors and filling processes is reducing manual labor costs. The projected P/S ratio reflects market expectations, where the value is held at 2.30. This confirms Garo Armen's belief in the success of a broad drug portfolio and strategic alliances.
Agenus, Inc - rincian analitis lan metrik utama (AGEN)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- statistik nilai buku emiten:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Agenus|AGEN - Rasio utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Agenus|AGEN - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Agenus, Inc|AGEN - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Agenus|Rasio cepet agenusbio.com
- rincian asil keuangan lan kelipatan valuasi:
AGEN - Bathi resik taunan|Proyeksi bathi mangsa ngarep Agenus|AGEN - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Agenus Inc|AGEN - Rasio P/E diaturake wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Agenus, Inc|AGEN - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi resik saben saham (EPS TTM) Agenus|AGEN - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan agenusbio.com|AGEN - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Agenus
- data pendapatan lan penerimaan dodolan:
Analisis fundamental perusahaan:AGEN (Agenus Inc.)
Searching for fundamental stability requires analyzing the ratio of market capitalization to projected revenue, which allows for an assessment of market expectations regarding future cash flows. The forward P/S dynamics of Agenus (AGEN) reflect investor sensitivity to sales scalability, considering the risks of dependence on external CMOs and CROs during the implementation of biotechnological developments, where sharp fluctuations in the curve signal a reassessment of commercialization potential.
Analisis perusahaan pesaing
Multiplikator Forward P/S ARGX (argenx)|BioNTech Inc. (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Abivax Corp - Multiplikator Forward P/S|ADMA - Multiplikator Forward P/S|PTGX: Multiplikator Forward P/S|Prakiraan rega marang pendapatan immunovant.com IMVT|KNSA (Kiniksa) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Grifols SA GRFS|Rasio rega marang prakiraan pendapatan Adaptive Biotechnologies Corp (ADPT)|Celldex Corp - Kapitalisasi marang prakiraan pendapatan|Aurinia Pharmaceuticals - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S biocryst.com BCRX|VERA - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Dianthus Therapeutics Inc DNTH|PHVS: Multiplikator Forward P/S|AbCellera Corp (ABCL) - Multiplikator Forward P/S|TRML (Tourmaline Bio, Inc.) - Multiplikator Forward P/S|PGEN - Prakiraan rega marang pendapatan|Multiplikator Forward P/S PHAR|NKTR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Upstream Bio Corp UPB|ZBIO: Kapitalisasi marang prakiraan pendapatan|IMNM - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan GOSS|KALV: Multiplikator Forward P/S|Septerna, Inc. - Rega forward marang dodolan|PVLA (Pieris Pharmaceuticals Inc) - Multiplikator Forward P/S|Multiplikator Forward P/S Savara Pharma|Rasio rega marang prakiraan pendapatan Rigel Pharmaceuticals (RIGL)|ANAB (anaptysbio.com) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Astria Therapeutics, Inc. ATXS|ENGN - Multiplikator forward rega marang pendapatan|RAPT Therapeutics, Inc. - Multiplikator Forward P/S|JBIO - Multiplikator Forward P/S|ACRS (Aclaris Therapeutics) - Multiplikator forward rega marang pendapatan|kyvernatx.com - Rega forward marang dodolan|TLSA (Tiziana Life Sciences Ltd) - Multiplikator Forward P/S|Cabaletta Bio Inc. (CABA) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Ventyx Bio (VTYX)|Multiplikator forward rega marang pendapatan Theratechnologies, Inc THTX|Rasio rega marang prakiraan pendapatan Avalo Therapeutics, Inc AVTX|ELDN - Multiplikator forward rega marang pendapatan|CLYM: Multiplikator forward rega marang pendapatan|ZURA - Multiplikator Forward P/S|aTyr (ATYR) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan ADAG|IMA (ImageneBio) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Shattuck Therapeutics STTK|Multiplikator Forward P/S EQ|Multiplikator Forward P/S connectbiopharm.com (CNTB)|Multiplikator Forward P/S IMUX (Immunic)|Prakiraan rega marang pendapatan Atara Biotherapeutics, Inc.|InflaRx GmbH - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep x4pharma.com|adicetbio.com (ACET) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan CELU|Multiplikator forward rega marang pendapatan INMB|Multiplikator Forward P/S Barinthus Biotherapeutics Corp|Rasio rega marang prakiraan pendapatan Kezar Life Sciences (KZR)|Rasio kapitalisasi marang dodolan sing dikarepake sabbiotherapeutics.com|Multiplikator Forward P/S AKTX (Akari Therapeutics Plc)|Multiplikator Forward P/S Enlivex Therapeutics Ltd ENLV|Q32 Bio Corp - Multiplikator Forward P/S|Prakiraan rega marang pendapatan GeoVax Corp (GOVX)|EDSA: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ibioinc.com (IBIO)|Rasio rega marang prakiraan pendapatan Carisma Therapeutics Inc|Kapitalisasi marang prakiraan pendapatan XTLB (XTL Biopharmaceuticals Ltd)|Rasio rega marang prakiraan pendapatan Bolt Biotherapeutics (BOLT)|HCWB: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S APVO (Aptevo Therapeutics Inc.)|Rega forward marang dodolan AIM|Aditxt Corp - Multiplikator Forward P/S|GRI - Multiplikator Forward P/S|XORTX (XRTX) - Rasio rega marang prakiraan pendapatan|Vyome Therapeutics - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Revelation Biosciences|Multiplikator forward rega marang pendapatan indaptusrx.com (INDP)|Multiplikator Forward P/S SCNI|Multiplikator Forward P/S calcimedica.com (CALI)|Affimed N.V. - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan ALLK|HOOKIPA - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IGM Biosciences, Inc. IGMS|iTeos Therapeutics, Inc. (ITOS) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Ocean Biomedical Inc|Rasio rega marang prakiraan pendapatan TC BioPharm (Holdings) PLC|Multiplikator forward rega marang pendapatan Third Harmonic Bio Inc (THRD)
